An aggressive functioning pituitary adenoma treated with peptide receptor radionuclide therapy
Image of the Month
- 41 Downloads
Part of the following topical collections:
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
The patient was informed and signed a consent form.
- 3.Baldari S, Ferrau F, Alafaci C, Herberg A, Granata F, Militano V, et al. First demonstration of the effectiveness of peptide receptor radionuclide therapy (PRRT) with 111In-DTPA-octreotide in a giant PRL-secreting pituitary adenoma resistant to conventional treatment. Pituitary. 2012;15(Suppl 1):S57–60.CrossRefGoogle Scholar
- 4.Dworakowska D., Grossman A. B. Aggressive and malignant pituitary tumours: state-of-the-art, Endocr Relat Cancer 2018.Google Scholar
© Springer-Verlag GmbH Germany, part of Springer Nature 2019